- Home
- AUDC vs IMRX Comparison
AUDC vs IMRX Comparison
Compare AUDC & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUDC
- IMRX
- Stock Information
- Founded
- AUDC 1992
- IMRX 2008
- Country
- AUDC Israel
- IMRX United States
- Employees
- AUDC N/A
- IMRX N/A
- Industry
- AUDC Telecommunications Equipment
- IMRX Biotechnology: Pharmaceutical Preparations
- Sector
- AUDC Utilities
- IMRX Health Care
- Exchange
- AUDC Nasdaq
- IMRX Nasdaq
- Market Cap
- AUDC 282.4M
- IMRX 232.9M
- IPO Year
- AUDC 1999
- IMRX 2021
- Fundamental
- Price
- AUDC $9.62
- IMRX $6.21
- Analyst Decision
- AUDC Buy
- IMRX Strong Buy
- Analyst Count
- AUDC 3
- IMRX 4
- Target Price
- AUDC $11.67
- IMRX $17.75
- AVG Volume (30 Days)
- AUDC 106.0K
- IMRX 3.5M
- Earning Date
- AUDC 11-05-2025
- IMRX 11-12-2025
- Dividend Yield
- AUDC 4.15%
- IMRX N/A
- EPS Growth
- AUDC 3.22
- IMRX N/A
- EPS
- AUDC 0.46
- IMRX N/A
- Revenue
- AUDC $243,249,000.00
- IMRX N/A
- Revenue This Year
- AUDC $2.52
- IMRX N/A
- Revenue Next Year
- AUDC $1.74
- IMRX N/A
- P/E Ratio
- AUDC $21.10
- IMRX N/A
- Revenue Growth
- AUDC N/A
- IMRX N/A
- 52 Week Low
- AUDC $7.70
- IMRX $1.10
- 52 Week High
- AUDC $12.72
- IMRX $10.08
- Technical
- Relative Strength Index (RSI)
- AUDC 45.64
- IMRX 47.03
- Support Level
- AUDC $9.62
- IMRX $6.02
- Resistance Level
- AUDC $9.86
- IMRX $9.54
- Average True Range (ATR)
- AUDC 0.23
- IMRX 0.96
- MACD
- AUDC -0.04
- IMRX -0.36
- Stochastic Oscillator
- AUDC 21.50
- IMRX 4.68
About AUDC AudioCodes Ltd.
AudioCodes Ltd develops and sells onverged voice over IP and data networking solutions, products and applications to service providers and channels, OEMs, network equipment providers and system integrators. Its products include IP phones, session border controllers, voice applications, multi-service business routers, digital and analog media gateways, among others. The company generates revenues from the sale of products through a direct sales force and sales representatives. Its geographic segments are Israel, Americas, Europe, and the Far East. It derives a majority of the revenues from Americas segment.
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.